Acute coronary syndrome in the patient with diabetes: is the management different?
Diabetic patients who present with an acute coronary syndrome (ACS) have a particularly adverse prognosis, largely contributed by increased platelet reactivity and higher burden of disease severity. Diabetic patients with ACS derive a greater benefit from established therapies, particularly platelet-inhibiting therapies, including clopidogrel pretreatment, and glycoprotein IIb/IIIa inhibitor use. Recent data show intense ADP-P2Y12 platelet receptor inhibition with prasugrel is of particular clinical value in the diabetic patient with ACS, without excessive bleeding. Diabetic patients with ACS also benefit more from aggressive revascularization strategies. Recent data show the benefit of drug-eluting stents in the setting of primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in decreasing target vessel revascularization up to 2 years, particularly in patients at highest risk for restenosis with bare metal stents (likely diabetic patients). This review summarizes the data supporting the key pharmacologic and revascularization management strategies to guide the clinician in taking care of diabetic patients who present with an ACS event.
Amin
Amit P
AP
Saint Luke's Mid America Heart Institute, 4401 Wornall Road, Kansas City, MO 64111, USA.
Marso
Steven P
SP
D054058:Acute Coronary Syndrome / Q000188:drug therapy* / Q000401:mortality / Q000628:therapy; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000627:therapeutic use; D000077144:Clopidogrel; D003920:Diabetes Mellitus / Q000503:physiopathology / Q000517:prevention & control*; D054855:Drug-Eluting Stents; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors; D000068799:Prasugrel Hydrochloride; D012307:Risk Factors; D013876:Thiophenes / Q000627:therapeutic use*; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000627:therapeutic use
D000925:Anticoagulants; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D019039:Platelet Glycoprotein GPIIb-IIIa Complex; D013876:Thiophenes; D000077144:Clopidogrel; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine
Diabetes Care. 2006 Jan;29(1):9-14
16373888
Eur Heart J. 2007 May;28(10):1193-204
17456480
Diabetes Care. 2009 Jan;32 Suppl 1:S13-61
19118286
Circulation. 2007 Mar 27;115(12):1544-50
17353438
N Engl J Med. 2009 May 7;360(19):1946-59
19420364
Circulation. 2001 Dec 4;104(23):2767-71
11733392
N Engl J Med. 2005 Mar 24;352(12):1179-89
15758000
JAMA. 2008 Feb 6;299(5):532-9
18252883
J Am Coll Cardiol. 2008 Apr 29;51(17):1645-52
18436116
Lancet. 2009 May 30;373(9678):1849-60
19482214
Circulation. 2004 Dec 14;110(24):3627-35
15531766
Lancet. 2001 Aug 18;358(9281):527-33
11520521
Lancet. 2005 Nov 5;366(9497):1607-21
16271642
Eur Heart J. 2003 Jun;24(12):1087-103
12804923
N Engl J Med. 2001 Aug 16;345(7):494-502
11519503
Diabetes Care. 2004 May;27(5):1047-53
15111519
Diabetes Care. 2006 Aug;29(8):1931-2
16873808
Diabetes. 2005 Aug;54(8):2430-5
16046311
N Engl J Med. 2001 Jun 21;344(25):1879-87
11419424
JAMA. 2009 May 13;301(18):1909-19
19436018
Circulation. 1999 May 4;99(17):2239-42
10226087
JAMA. 2005 Sep 14;294(10):1224-32
16143698
N Engl J Med. 2008 May 22;358(21):2218-30
18499566
Vasc Health Risk Manag. 2009;5(1):101-19
19436654
Lancet. 2000 Jul 1;356(9223):9-16
10892758
J Am Coll Cardiol. 2001 Jul;38(1):143-9
11451264
JAMA. 2005 Nov 23;294(20):2594-600
16304073
Diabetes. 2006 Mar;55(3):780-4
16505243
J Am Coll Cardiol. 2002 Sep 4;40(5):946-53
12225721
Lancet. 1996 Nov 16;348(9038):1329-39
8918275
Am J Cardiol. 2006 Jan 1;97(1):38-43
16377281
J Am Coll Cardiol. 2009 May 5;53(18):1677-89
19406344
Circulation. 2000 Oct 31;102(18):2180-4
11056089
Am J Cardiol. 2002 Sep 15;90(6):625-8
12231089
N Engl J Med. 2006 Nov 23;355(21):2203-16
17124018
J Am Coll Cardiol. 2006 Jul 18;48(2):298-304
16843179
BMJ. 2009 Nov 06;339:b4531
19897665
J Am Coll Cardiol. 2007 Aug 14;50(7):e1-e157
17692738
JAMA. 2006 Apr 5;295(13):1531-8
16533938
JAMA. 2004 Jul 7;292(1):55-64
15238591
Am J Cardiol. 2008 Feb 1;101(3):303-7
18237589
Diabetes Care. 2004 Jan;27 Suppl 1:S72-3
14693931
Am Heart J. 2003 Jan;145(1):47-57
12514654
Lancet. 1994 Feb 5;343(8893):311-22
7905143
Diabetes Care. 2003 Jul;26(7):2181-8
12832332